An evaluation of the enhanced multidisciplinary care program for the patients of the patioents with Parkison's disease and Parkison's syndrome

An evaluation of the enhanced multidisciplinary care program for the patients of the patioents with Parkison's disease and Parkison's syndrome - An evaluation of the enhanced multidisciplinary care program for the patients of the patioents with Parkison's disease and Parkison's syndrome

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000054116

Enrollment

100

Registered

2024-04-15

Start date

2024-05-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson&#39

Interventions

We coprehensively and regulary evaluate the clinical symptoms, medioction, home enviroment, etc of each patient. Then, we introduce &#39

the enhanced multidisciplinary care program&#39

that main interventions are reviced according to each need.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Those who meet Parkison's disease criteria for 2015 International Parkinson and Movement Disorder Society Those who meet dementia with Lewy bodies criteria for Fourth consensus report of the DLB Consortium Those who are diagnosed with the other Parkison's syndrome (Vascular Parkison's synrome, Progressive Supranuclear Palsy, Corticobasal degeneration, Multiple System Atrophy, etc) Those who can underestand the informed consent

Exclusion criteria

Exclusion criteria: Those who have Past medical history of Psychiatoric disease Those who complicate organic brain diseases (include cerebral infarction) except the concerned disease, and take medicines that affect the central nervous system Those who are pregnant, or breastfeeding

Design outcomes

Primary

Measure	Time frame
Evaluation of the Quality of life	—

Secondary

Measure	Time frame
All items measured before the intervention, after 6 motnths and 1 year Motor symptoms (UPDRS) Non motor symptoms (UPDRS) Status of the multi multidisciplinary care Neuropsychological tests Bathel Index Details of Medication	—

Countries

Japan

Contacts

Public ContactYoshiaki Ito

Osaka Metropolitan University Hospital Department of Neurology

a21337r@omu.ac.jp06-6645-3889

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026

An evaluation of the enhanced multidisciplinary care program for the patients of the patioents with Parkison&#39;s disease and Parkison&#39;s syndrome